Lipa Meir & Co. regularly advises clients in cross-border transactions, especially in Europe and the U.S. We represents our clients in all aspects of cross-border transactions, including joint ventures, banking and finance, commercial, corporate governance and mergers and acquisitions. We also advises clients, together with applicable local counsel in the relevant jurisdiction, to establish subsidiary or operations abroad.
We draw on the capabilities and experience of our partners and lawyers, who work on regular basis on cross-border transactions. Some of them studied in the United States and work in prestige law firm in the United States for several years. We recently advised on cross-border transactions in the U.S., Germany, Netherland, U.K., Spain and Poland.
Our experience and capabilities enabling us to meet the needs and demands of our clients, while tailoring an effective and efficient legal representations with the assistance of local counsel in the relevant jurisdiction, as needed.
News & Publications
FutureMed 2020 – Online Conference
The first wave of the CoronaVirus pandemic has hit every sphere of public and private life. Different governments have presented different approaches, all of which have been asked to plan and adopt health management and new regulations on the move, while no one has an unequivocal answer to the key question: What is the right […]
How has Israel coped with COVID-19
Alon Pomeranc, Managing Partner and Head of Litigation & Dispute Resolution Department answer about how he feel the crisis has been handled in Israel: “Even though the numbers of people infected with COVID-19 and deaths in Israel are not high relative to other countries, I am not sure the crisis was handled that well. I […]
The Legal 500 Europe, Middle East & Africa 2020 rankings released
Lipa Meir & Co has been recommended as a TOP-TIER FIRM in 3 practice areas: – Energy – Healthcare and life sciences – Restructuring and insolvency Lipa Meir & Co has also been recommended in the following 13 practice areas: – Banking and finance – Capital markets – Commercial, corporate and M&A – Competition antitrust […]
The Covid-19 black swan muddies the M&A lake
A common closing condition in M&A agreements is that there has been no material adverse change (MAC clause), or material adverse effect (MAE clause) with respect to the target company and its business, from the date of signing the agreement until the closing of the transaction. In this article, we address whether the COVID 19 epidemic could be […]
A Black Swan in M&A COVID 19 Lake: A Material Adverse Effect that Could Strike at Merger and Acquisition Deals
Many mergers and acquisitions, including investments, have a time period between signing the transaction agreement and closing the transaction. Several factors may lead to that time period such as the need to obtain regulatory approvals (e.g., Competition Authority, the Israeli Lands Authority) to complete the transaction or to obtain the approval of the target company’s […]
You Exercised Your 102 Options to Shares As An Employee – You’re Not Necessarily a Shareholder
An employee exercising options to company’s shares is not necessarily a shareholder with shareholders rights as long as those shares are held by the trustee According to a recent decision in the Haifa District Court – Civil Case 19042-03-18 Navon vs. Sol Chip Ltd. – an employee has been granted options to purchase shares of […]
Singapore a Perfect Place for Fundraising and IPO’s
Singapore is well known as a regional hub, as far as capital markets, business activities, and research and development are concerned. Among other things – thanks to its geopolitical positioning, its thriving economy and its business-friendly and efficient approach. Moreover, the close relations between the states, as well as their common “British” origins (and the […]
The Business Judgement Rule in Derivative Actions
In a recent judgment of the Israeli Supreme Court, a significant precedent was handed down by Judge Yoram Danziger, setting out that the Business Judgment Rule applies to a company’s board of directors when it is deciding whether to file a derivative action. The case brought before the Supreme Court dealt with a dispute between […]
China’s Newater to Acquire Water Purification Company AMS for $13.5 Million
We are proud to announce the acquisition of the Israeli start-up, AMS Technologies, by Newater, a Chinese public company traded on the NASDAQ. Both companies are engaged in the field of wastewater technologies. AMS was represented by Adv. Gary Copelovitz, Danit Rimon and Gad Keren of our firm. For the full article in Calcalist, click here